Dr Adri Voogd (A.C.)

Ding, N., Hermans, K. E. P. E., van Nijnatten, T. J. A., Engelen, S. M. E., Tol, J., Kooreman, L., Vrancken-Peeters, M. J. T. F. D., Siesling, S., Voogd, A. C., Tjan-Heijnen, V. C. G., & Geurts, S. M. E. (2025). Overall survival of patients with de Novo HER2-positive metastatic breast cancer in the Netherlands from 2008 to 2017: A population-based cohort study of systemically treated patients. European Journal of Cancer, 222, Article 115475. https://doi.org/10.1016/j.ejca.2025.115475

Walstra, C. J. E. F., Schipper, R. J., Voogd, A. C., van der Sangen, M. J. C., van Duin, R. T. N. W., van Riet, Y. E., Smidt, M. L., Bloemen, J. G., Wyndaele, D. N. J., Nieuwenhuijzen, G. A. P., & Dutch Snapshot Research Group (2025). The role of ¹⁸F-FDG PET/CT in detecting synchronous regional and distant metastatic disease in patients with an in-breast tumour recurrence. European Journal of Surgical Oncology, 51(5), Article 109564. https://doi.org/10.1016/j.ejso.2024.109564

van der Veer, E. L., Coolen, A. M. P., Bluekens, A. M. J., Generaal, M. I., Schipper, R. J., Setz-Pels, W., van Uden, D. J. P., Voogd, A. C., & Duijm, L. E. M. (2025). Interhospital variation in surgical treatment of screen-detected breast cancer in the South of the Netherlands. Breast, 80, Article 103886. https://doi.org/10.1016/j.breast.2025.103886

Ploumen, R. A. W., van Nijnatten, T. J. A., Kooreman, L. F. S., Voogd, A. C., Keymeulen, K. B. M. I., Siesling, S., & Smidt, M. L. (2025). Surgical treatment after neoadjuvant systemic therapy for HER2-positive invasive breast cancer in the Netherlands: 10-Year trends and the influence an accompanying DCIS component. Breast, 79, Article 103854. https://doi.org/10.1016/j.breast.2024.103854

de Bruijn, A., Schipper, R.-J., Voogd, A. C., Pullens, M. J. J., Bloemen, J. G., de Munck, L., van Riet, Y. E., Siesling, S., Vriens, B. E. P., & Nieuwenhuijzen, G. A. P. (2024). Adding Anti-HER2 Therapy to Neoadjuvant Endocrine Therapy Seems Effective in Hormone Receptor and HER2 Positive Breast Cancer Patients Unfit for Chemotherapy: A Nationwide Population-Based Cohort Study. Cancers, 16(24), Article 4188. https://doi.org/10.3390/cancers16244188

van der Veer, E. L., Rozemond, F., Generaal, M. I., Bluekens, A. M. J., Coolen, A. M. P., Voogd, A. C., & Duijm, L. E. M. (2024). Interhospital variations in diagnostic work-up following recall at biennial screening mammography-a population-based study. European Radiology. Advance online publication. https://doi.org/10.1007/s00330-024-11302-5

de Jonge, C., Schipper, R.-J., Walstra, C. J. E. F., Van Riet, Y. E., Verrijssen, A.-S. E., Voogd, A. C., van der Sangen, M. J. C., Theuws, J., Degreef, E., Gielens, M. P. M., Bloemen, J. G., van den Berg, H. A., & Nieuwenhuijzen, G. A. P. (2024). Breast conserving surgery with intraoperative electron beam radiation therapy for low-risk breast cancer: Five-year follow-up of 306 patients. International Journal of Cancer, 155(7), 1237-1247. https://doi.org/10.1002/ijc.35033

Strijbos, B. T. M., Janssen, L., Voogd, A. C., Zwaans, W. A. R., Roumen, R. M. H., & Maaskant-Braat, A. J. G. (2024). ASO Author Reflections: Persistent Pain After Breast Cancer Treatment, an Underreported Burden for Breast Cancer Survivors. Annals of Surgical Oncology, 31(10), 6845-6846. https://doi.org/10.1245/s10434-024-15855-z

Strijbos, B. T. M., Janssen, L., Voogd, A. C., Zwaans, W. A. R., Roumen, R. M. H., & Maaskant-Braat, A. J. G. (2024). Persistent Pain After Breast Cancer Treatment, an Underreported Burden for Breast Cancer Survivors. Annals of Surgical Oncology, 31(10), 6753-6763. https://doi.org/10.1245/s10434-024-15682-2

O'Leary, R. L., Duijm, L. E. M., Boersma, L. J., van der Sangen, M. J. C., de Munck, L., Wesseling, J., Schipper, R.-J., & Voogd, A. C. (2024). Invasive recurrence after breast conserving treatment of ductal carcinoma in situ of the breast in the Netherlands: time trends and the association with tumour grade. British Journal of Cancer, 131(5), 852-859. https://doi.org/10.1038/s41416-024-02785-6